Lung Tumorigenesis Alters the Expression of Slit2-exon15 Splicing Variants in Tumor Microenvironment
Slit2 expression is downregulated in various cancers, including lung cancer. We identified two Slit2 splicing variants at exon15—Slit2-WT and Slit2-ΔE15. In the RT-PCR analyses, the Slit2-WT isoform was predominantly expressed in all the lung cancer specimens and in their normal l...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/2/166 |
id |
doaj-6a2a87cc8c5c4677b76c97af710711f0 |
---|---|
record_format |
Article |
spelling |
doaj-6a2a87cc8c5c4677b76c97af710711f02020-11-25T01:13:40ZengMDPI AGCancers2072-66942019-02-0111216610.3390/cancers11020166cancers11020166Lung Tumorigenesis Alters the Expression of Slit2-exon15 Splicing Variants in Tumor MicroenvironmentMing-Fang Wu0Cheng-Yen Chuang1Pinpin Lin2Wei-Ting Chen3Shang-Er Su4Chen-Yi Liao5Ming-Shiou Jan6Jinghua Tsai Chang7School of Medicine, Chung Shan Medical University, Taichung 40201, TaiwanDivision of Thoracic Surgery, Taichung Veterans General Hospital, Taichung 40705 TaiwanNational Institute of Environmental Health Sciences, National Health Research Institutes, Zhunan 35053, TaiwanInstitute of Medicine, Chung Shan Medical University, Taichung 40201, TaiwanInstitute of Medicine, Chung Shan Medical University, Taichung 40201, TaiwanInstitute of Medicine, Chung Shan Medical University, Taichung 40201, TaiwanDepartment of Microbiology and Immunology, Chung Shan Medical University, Taichung 40201, TaiwanDivisions of Medical Oncology and Pulmonary Medicine, Chung Shan Medical University Hospital, Taichung 40201, TaiwanSlit2 expression is downregulated in various cancers, including lung cancer. We identified two Slit2 splicing variants at exon15—Slit2-WT and Slit2-ΔE15. In the RT-PCR analyses, the Slit2-WT isoform was predominantly expressed in all the lung cancer specimens and in their normal lung counterparts, whereas Slit2-ΔE15 was equivalently or predominantly expressed in 41% of the pneumothorax specimens. A kRas<sup>G12D</sup> transgenic mice system was used to study the effects of tumorigenesis on the expressions of the Slit2-exon15 isoforms. The results revealed that a kRas<sup>G12D</sup>-induced lung tumor increased the Slit2-WT/Slit2-ΔE15 ratio and total Slit2 expression level. However, the lung tumors generated via a tail vein injection of lung cancer cells decreased the Slit2-WT/Slit2-ΔE15 ratio and total Slit2 expression level. Interestingly, the lipopolysaccharide (LPS)-induced lung inflammation also decreased the Slit2-WT/Slit2-ΔE15 ratio. Since Slit2 functions as an anti-inflammatory factor, the expression of Slit2 increases in kRas<sup>G12D</sup> lungs, which indicates that Slit2 suppresses immunity during tumorigenesis. However, an injection of lung cancer cells via the tail vein and the LPS-induced lung inflammation both decreased the Slit2 expression. The increased Slit2 in the tumor microenvironment was mostly Slit2-WT, which lacks growth inhibitory activity. Thus, the results of our study suggested that the upregulation of Slit2-WT, but not Slit2-ΔE15, in a cancer microenvironment is an important factor in suppressing immunity while not interfering with cancer growth.https://www.mdpi.com/2072-6694/11/2/166Slit2 splicing variantslung cancerpneumothoraxtumor microenvironmentkRas<sup>G12D</sup>LPS treatmentinflammation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ming-Fang Wu Cheng-Yen Chuang Pinpin Lin Wei-Ting Chen Shang-Er Su Chen-Yi Liao Ming-Shiou Jan Jinghua Tsai Chang |
spellingShingle |
Ming-Fang Wu Cheng-Yen Chuang Pinpin Lin Wei-Ting Chen Shang-Er Su Chen-Yi Liao Ming-Shiou Jan Jinghua Tsai Chang Lung Tumorigenesis Alters the Expression of Slit2-exon15 Splicing Variants in Tumor Microenvironment Cancers Slit2 splicing variants lung cancer pneumothorax tumor microenvironment kRas<sup>G12D</sup> LPS treatment inflammation |
author_facet |
Ming-Fang Wu Cheng-Yen Chuang Pinpin Lin Wei-Ting Chen Shang-Er Su Chen-Yi Liao Ming-Shiou Jan Jinghua Tsai Chang |
author_sort |
Ming-Fang Wu |
title |
Lung Tumorigenesis Alters the Expression of Slit2-exon15 Splicing Variants in Tumor Microenvironment |
title_short |
Lung Tumorigenesis Alters the Expression of Slit2-exon15 Splicing Variants in Tumor Microenvironment |
title_full |
Lung Tumorigenesis Alters the Expression of Slit2-exon15 Splicing Variants in Tumor Microenvironment |
title_fullStr |
Lung Tumorigenesis Alters the Expression of Slit2-exon15 Splicing Variants in Tumor Microenvironment |
title_full_unstemmed |
Lung Tumorigenesis Alters the Expression of Slit2-exon15 Splicing Variants in Tumor Microenvironment |
title_sort |
lung tumorigenesis alters the expression of slit2-exon15 splicing variants in tumor microenvironment |
publisher |
MDPI AG |
series |
Cancers |
issn |
2072-6694 |
publishDate |
2019-02-01 |
description |
Slit2 expression is downregulated in various cancers, including lung cancer. We identified two Slit2 splicing variants at exon15—Slit2-WT and Slit2-ΔE15. In the RT-PCR analyses, the Slit2-WT isoform was predominantly expressed in all the lung cancer specimens and in their normal lung counterparts, whereas Slit2-ΔE15 was equivalently or predominantly expressed in 41% of the pneumothorax specimens. A kRas<sup>G12D</sup> transgenic mice system was used to study the effects of tumorigenesis on the expressions of the Slit2-exon15 isoforms. The results revealed that a kRas<sup>G12D</sup>-induced lung tumor increased the Slit2-WT/Slit2-ΔE15 ratio and total Slit2 expression level. However, the lung tumors generated via a tail vein injection of lung cancer cells decreased the Slit2-WT/Slit2-ΔE15 ratio and total Slit2 expression level. Interestingly, the lipopolysaccharide (LPS)-induced lung inflammation also decreased the Slit2-WT/Slit2-ΔE15 ratio. Since Slit2 functions as an anti-inflammatory factor, the expression of Slit2 increases in kRas<sup>G12D</sup> lungs, which indicates that Slit2 suppresses immunity during tumorigenesis. However, an injection of lung cancer cells via the tail vein and the LPS-induced lung inflammation both decreased the Slit2 expression. The increased Slit2 in the tumor microenvironment was mostly Slit2-WT, which lacks growth inhibitory activity. Thus, the results of our study suggested that the upregulation of Slit2-WT, but not Slit2-ΔE15, in a cancer microenvironment is an important factor in suppressing immunity while not interfering with cancer growth. |
topic |
Slit2 splicing variants lung cancer pneumothorax tumor microenvironment kRas<sup>G12D</sup> LPS treatment inflammation |
url |
https://www.mdpi.com/2072-6694/11/2/166 |
work_keys_str_mv |
AT mingfangwu lungtumorigenesisalterstheexpressionofslit2exon15splicingvariantsintumormicroenvironment AT chengyenchuang lungtumorigenesisalterstheexpressionofslit2exon15splicingvariantsintumormicroenvironment AT pinpinlin lungtumorigenesisalterstheexpressionofslit2exon15splicingvariantsintumormicroenvironment AT weitingchen lungtumorigenesisalterstheexpressionofslit2exon15splicingvariantsintumormicroenvironment AT shangersu lungtumorigenesisalterstheexpressionofslit2exon15splicingvariantsintumormicroenvironment AT chenyiliao lungtumorigenesisalterstheexpressionofslit2exon15splicingvariantsintumormicroenvironment AT mingshioujan lungtumorigenesisalterstheexpressionofslit2exon15splicingvariantsintumormicroenvironment AT jinghuatsaichang lungtumorigenesisalterstheexpressionofslit2exon15splicingvariantsintumormicroenvironment |
_version_ |
1725160770048622592 |